Keith Speights
Keith Speights is a contributing Motley Fool Healthcare Analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University. Fun fact: His first job was a DJ at a country music radio station. He initially hated country music, but it grew on him over time.
Recent Articles by Keith Speights

3 Stocks I Plan to Hold for the Next 20 Years

3 Red-Hot Growth Stocks to Buy in 2025

Could Buying IonQ Stock Set You Up for Life?

3 Dividend Stocks to Double Up on Right Now

Got $500? 2 Healthcare Stocks to Buy and Hold Forever

2 Tech Stocks You Can Buy and Hold for the Next Decade

Most Volatile Stocks in 2025
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.